199 related articles for article (PubMed ID: 12470983)
1. Cancer vaccination progress.
Pawelec G; Rees RC
Trends Mol Med; 2002 Dec; 8(12):545-6. PubMed ID: 12470983
[TBL] [Abstract][Full Text] [Related]
2. [Tumor vaccines-therapeutic vaccination against cancer].
Rammensee HG; Löffler MW; Walz JS; Bokemeyer C; Haen SP; Gouttefangeas C
Internist (Berl); 2020 Jul; 61(7):690-698. PubMed ID: 32462251
[TBL] [Abstract][Full Text] [Related]
3. Tumor-specific antigens and immunologic adjuvants in cancer immunotherapy.
Seremet T; Brasseur F; Coulie PG
Cancer J; 2011; 17(5):325-30. PubMed ID: 21952282
[TBL] [Abstract][Full Text] [Related]
4. Vaccination with T cell-defined antigens: biological basis and clinical applications.
Parmiani G
Tumori; 2001; 87(6):S10. PubMed ID: 11989607
[No Abstract] [Full Text] [Related]
5. The Twelfth International Conference on Progress in Vaccination Against Cancer (PIVAC 12), Nottingham, UK, 11-13 September 2012: insights into the dynamics of anti-tumour immunity and the development of cancer vaccines.
Malhi SK; Saif J; Vadakekolathu JN
Cancer Immunol Immunother; 2013 Aug; 62(8):1431-7. PubMed ID: 23764928
[No Abstract] [Full Text] [Related]
6. International conference: progress in vaccination against cancer (PIVAC) 2002, Nottingham, UK.
Rees RC; Robins RA; Pawelec G; Muller L; Li G; Spendlove I
Cancer Immunol Immunother; 2003 Jun; 52(6):403-7. PubMed ID: 12684847
[No Abstract] [Full Text] [Related]
7. [Perspectives for tumour immunology: antigen-specific immunotherapy of malignant diseases].
Jäger E; Jäger D; Knuth A
Dtsch Med Wochenschr; 2001 Sep; 126(37):1011-6. PubMed ID: 11555776
[No Abstract] [Full Text] [Related]
8. Peptide-based vaccines for cancer therapy.
Parmiani G; Russo V; Maccalli C; Parolini D; Rizzo N; Maio M
Hum Vaccin Immunother; 2014; 10(11):3175-8. PubMed ID: 25483658
[TBL] [Abstract][Full Text] [Related]
9. [General principles and first clinical trials of therapeutic vaccines against cancer].
Baurain JF; Van der Bruggen P; Van den Eynde BJ; Coulie PG; Van Baren N
Bull Cancer; 2008 Mar; 95(3):327-35. PubMed ID: 18390413
[TBL] [Abstract][Full Text] [Related]
10. A power surge for cancer immunotherapy: antibodies, vaccines, and engineered T cells fuel new optimism.
Nelson B
Cancer Cytopathol; 2014 Jan; 122(1):1-2. PubMed ID: 24424750
[No Abstract] [Full Text] [Related]
11. Human Tumor Antigens and Cancer Immunotherapy.
Vigneron N
Biomed Res Int; 2015; 2015():948501. PubMed ID: 26161423
[TBL] [Abstract][Full Text] [Related]
12. New cancer vaccine approaches.
Kaplan JM
Drugs Today (Barc); 2004 Nov; 40(11):913-29. PubMed ID: 15645004
[TBL] [Abstract][Full Text] [Related]
13. Editorial: Approaches to Advance Cancer Vaccines to Clinical Utility.
Van Nuffel AMT; Boudousquié C; Tuyaerts S
Front Immunol; 2019; 10():2032. PubMed ID: 31507617
[No Abstract] [Full Text] [Related]
14. Tumor vaccine: current trends in antigen specific immunotherapy.
Baral R
Indian J Exp Biol; 2005 May; 43(5):389-406. PubMed ID: 15900903
[TBL] [Abstract][Full Text] [Related]
15. Glioma antigen.
Toda M
Adv Exp Med Biol; 2012; 746():77-84. PubMed ID: 22639160
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of cellular immune responses in cancer vaccine recipients: lessons from NY-ESO-1.
Cebon J; Knights A; Ebert L; Jackson H; Chen W
Expert Rev Vaccines; 2010 Jun; 9(6):617-29. PubMed ID: 20518717
[TBL] [Abstract][Full Text] [Related]
17. Cancer vaccines: finding the best way to train the immune system.
Goldman B
J Natl Cancer Inst; 2002 Oct; 94(20):1523-6. PubMed ID: 12381703
[No Abstract] [Full Text] [Related]
18. Rational peptide-based tumour vaccine development and T cell monitoring.
Scheibenbogen C; Letsch A; Schmittel A; Asemissen AM; Thiel E; Keilholz U
Semin Cancer Biol; 2003 Dec; 13(6):423-9. PubMed ID: 15001161
[TBL] [Abstract][Full Text] [Related]
19. Tumour immunology, vaccination and escape strategies.
García-Lora A; Algarra I; Collado A; Garrido F
Eur J Immunogenet; 2003 Jun; 30(3):177-83. PubMed ID: 12786993
[TBL] [Abstract][Full Text] [Related]
20. T cell response to tumor antigens and its therapeutic use in cancer patients.
Parmiani G; Castelli C; Dalerba P; Rivoltini L
Adv Exp Med Biol; 2001; 495():403-10. PubMed ID: 11774601
[No Abstract] [Full Text] [Related]
[Next] [New Search]
